Refractive surgery current status: expanding options

Mark Packer
DOI: https://doi.org/10.1080/17469899.2022.2108405
2022-08-07
Expert Review of Ophthalmology
Abstract:Independence from eyeglasses and contact lenses has significant value: 'The global refractive surgery devices market size was valued at USD 168.2 million in 2020 and is expected to expand at a compound annual growth (CAGR) of 7.7% from 2021 to 2028' [ 1 ]. In addition, 'Global demand for refractive surgical procedures (laser refractive surgery, presbyopia-correcting surgery, RLE [Refractive Lens Exchange], and phakic IOL implantation) is expected to grow at a compound annual rate of 9.6% from 2020 to 2025, with annual surgical volume increasing from 3.6 million to 5.8 million procedures' [ 2 ]. Considering the United States alone, it has been reported that 'The vision correction market generated professional service fees of over 6.3 billion mainly provided by independent eye care providers' [ 3 ]. These numbers reflect the high levels of satisfaction achieved with refractive procedures. For example, '98.7% of all patients were satisfied or very satisfied after their LASIK surgery' [ 4 ], and '99.4% of 1,542 patients surveyed' stated that they would elect to have the EVO implantable collamer lens (ICL) again [ 5 ]. As options for refractive correction have increased, the range of potential surgical candidates has broadened. Today, procedures are available for virtually any type of refractive error, as well as presbyopia.
What problem does this paper attempt to address?